5.90Open6.50Pre Close28 Volume88 Open Interest89.00Strike Price18.02KTurnover3737.23%IV0.23%PremiumAug 23, 2024Expiry Date6.56Intrinsic Value100Multiplier-1DDays to Expiry0.19Extrinsic Value100Contract SizeAmericanOptions Type-0.9938Delta0.0070Gamma12.54Leverage Ratio-78.9312Theta0.0000Rho-12.46Eff Leverage0.0000Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.